Inverse agonism

The Xth international symposium organized by the Esteve Foundation was held in S’Agaró (Girona, Spain; October 2-5, 2002). It was chaired by Adriaan IJzerman (Leiden/Amsterdam Center for Drug Research) and a total of 23 speakers completed the three days meeting. During the symposium important proof-of-concept was provided arround all the aspects of inverse agonism: in…

2002

3rd edition – Antequera, May, 6-7 2002

It was the third over five training seminars for members of the Spanish Research Ethics Committees. It was held Antequera (Malaga, 6-7 May 2002. Dr. Josep-E. Baños Dr. Josep-E. Baños (Department of Experimental and Health Sciences, Universitat Pompeu Fabra de Barcelona) and Dr. Maria Isabel Lucena (Department of Pharmacology, University of Malaga) were the teachers…

2002

Special collaboration: Center of Terminology of Catalonia: Terms of clinical research with medicinal products (2001)

Many terms in the field of medicinal products do not have a correct, normalized translation into Catalan. These terms are usually translated literally and incorrectly from English, or lack homogeneous, unifying criteria. Accordingly, an agreement was reached between the Esteve Foundation and TERMCAT (Center of Catalan Terminology, created by the Institut d’Estudis Catalans) to warrant the correct extension…

2001

Genome and drugs

On October 17, 2001, the Esteve Foundation and the Catalan Society of Pharmacology inaugurated the latter’s Academic Year 2001-2002 at the Academy of Medical Sciencies of Catalonia and the Balearic Islands with the lecture Genome and drugs, imparted by Prof. Julio Benítez Rodríguez, from the Department of Pharmacology and Psychiatry of the University of Extremadura.

2001

7th Award: Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2

This prize, offered biennially by the Esteve Foundation to the best work on pharmacological research, was awarded this year to María José Alcaraz and her collaborators for the study Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2, published in the British Journal of Pharmacology (volume 126,…

2001